Cash Flow Statement
Growth Metrics

Xtant Medical Holdings (XTNT) Short term Debt (2016 - 2025)

Xtant Medical Holdings has reported Short term Debt over the past 16 years, most recently at $10.9 million for Q4 2025.

  • Quarterly Short term Debt fell 10.42% to $10.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.9 million through Dec 2025, down 10.42% year-over-year, with the annual reading at $10.9 million for FY2025, 10.42% down from the prior year.
  • Short term Debt was $10.9 million for Q4 2025 at Xtant Medical Holdings, down from $11.3 million in the prior quarter.
  • Over five years, Short term Debt peaked at $16.5 million in Q1 2021 and troughed at $708000.0 in Q2 2023.
  • The 5-year median for Short term Debt is $4.3 million (2021), against an average of $6.8 million.
  • Year-over-year, Short term Debt skyrocketed 1648900.0% in 2021 and then plummeted 81.05% in 2023.
  • A 5-year view of Short term Debt shows it stood at $3.6 million in 2021, then dropped by 6.66% to $3.4 million in 2022, then surged by 36.79% to $4.6 million in 2023, then soared by 162.22% to $12.1 million in 2024, then dropped by 10.42% to $10.9 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Short term Debt are $10.9 million (Q4 2025), $11.3 million (Q3 2025), and $12.0 million (Q2 2025).